Vitamin B12 Glutathione Metabolic Balance GLP-1 Therapy Tirzepatide Semaglutide Longevity Programs NAD+ Injections Sermorelin Hair Growth Hormone Balance Weight Loss Vitamin B12 Glutathione Metabolic Balance GLP-1 Therapy Tirzepatide Semaglutide Longevity Programs NAD+ Injections Sermorelin Hair Growth Hormone Balance Weight Loss
Tirzepatide Safety Information — ILSA Health
ILSA Health — Safety Information

Tirzepatide
Safety Information

What every patient should understand before starting tirzepatide — the boxed warning, who should not use it, what to watch for, and exactly what to do if something doesn’t feel right. In an emergency, always call 911 first.

Read the Safety Information
RxPrescription Only
Weekly Injection
503ALicensed U.S. Pharmacies
FDAMedWatch 1-800-FDA-1088
Scroll
Overview

What tirzepatide is

Tirzepatide is a dual GIP and GLP-1 receptor agonist — a once-weekly injection given under the skin that works with your body’s own hormone signals to regulate appetite and blood sugar. Through the ILSA platform, tirzepatide is available only after an independent licensed provider reviews your health history and determines it is appropriate for you. If approved, it is prepared by a licensed U.S.-based 503A compounding pharmacy and shipped to your door.

This page summarizes important safety information. It does not replace the guidance of your provider or the instructions that come with your medication — always follow both, and ask your provider about anything you’re unsure of.

  • Once weekly. Inject on the same day each week, at any time of day, with or without food.
  • Rotate injection sites. Abdomen, thigh, or upper arm — use a different spot each week.
  • Missed dose? Take it within 4 days (96 hours) of the missed dose. If more time has passed, skip it and take the next dose on your regular day. Never take two doses within 3 days of each other.
  • Never share needles, syringes, or pens with anyone — even if the needle is changed.
  • Storage. Store as directed by your pharmacy, protect from light, and keep out of reach of children.
Boxed Warning

Risk of thyroid C-cell tumors

Possible thyroid tumors, including cancer

In studies with rodents, tirzepatide caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is not known whether tirzepatide causes thyroid C-cell tumors, including MTC, in people.

Do not use tirzepatide if you or any of your family have ever had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Tell your provider right away if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.

Contraindications

Who should not use tirzepatide

Tirzepatide is not appropriate for everyone. Do not use it — and tell your provider during your assessment — if any of the following apply to you.

  • You or a family member has had medullary thyroid carcinoma (MTC), or you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • You have had a serious allergic reaction to tirzepatide or any of its ingredients.
  • You are pregnant, planning to become pregnant, or breastfeeding. Tirzepatide may harm an unborn baby, and weight loss offers no benefit during pregnancy.
  • You have a history of pancreatitis, severe stomach or intestinal problems, or gastroparesis (slowed stomach emptying) — discuss these with your provider before starting.
  • You have type 1 diabetes. Tirzepatide is not a substitute for insulin and is not for people with type 1 diabetes.
  • You are under 18. Programs through the ILSA platform are for adults.

This list is not exhaustive. Your provider makes the final determination based on your complete health history — be thorough and honest in your intake.

Warnings & Precautions

What your provider watches for

These are the established risks of tirzepatide therapy. Your provider weighs each one against your health history before approving treatment — and monitors for them while you’re on it.

  • Pancreatitis. Inflammation of the pancreas has occurred. Stop use and contact your provider immediately if you have severe pain in your stomach area that will not go away, with or without vomiting — the pain may spread to your back.
  • Gallbladder problems. Gallstones and gallbladder inflammation have occurred, including with rapid weight loss. Watch for pain in your upper stomach, fever, yellowing of the skin or eyes, or clay-colored stools.
  • Low blood sugar. The risk is higher if you also take insulin or a sulfonylurea. Symptoms include shakiness, sweating, dizziness, fast heartbeat, confusion, and blurred vision. Your provider may adjust your other medications.
  • Kidney injury from dehydration. Nausea, vomiting, or diarrhea can cause fluid loss that strains the kidneys — especially if you have kidney problems already. Stay well hydrated, and contact your provider if you cannot keep fluids down.
  • Serious allergic reactions. Anaphylaxis and angioedema have been reported. Get emergency help — call 911 — for swelling of the face, lips, tongue, or throat, trouble breathing, severe rash, or fainting.
  • Vision changes with diabetes. If you have type 2 diabetes and a history of diabetic retinopathy, rapid improvement in blood sugar can temporarily worsen it. Report any vision changes to your provider.
  • Mood changes. Tell your provider about any history of depression or suicidal thoughts before starting, and report new or worsening mood symptoms right away. If you have thoughts of harming yourself, call or text 988 or seek emergency care.
  • Surgery and anesthesia. Because tirzepatide slows stomach emptying, tell every healthcare professional treating you — including surgeons, anesthesiologists, and dentists — that you take it before any procedure involving anesthesia or deep sedation.
Side Effects

What’s common — and what’s not

The most common side effects are digestive, tend to be strongest when starting or moving up a dose, and often ease as your body adjusts. Eating smaller meals, avoiding rich or greasy food, and staying hydrated all help.

  • Common: nausea, diarrhea, vomiting, constipation, decreased appetite, indigestion, stomach pain, burping, reflux, fatigue, hair shedding, and redness or irritation at the injection site.
  • Contact your provider promptly for: vomiting or diarrhea that prevents you from keeping fluids down; severe or persistent stomach pain; signs of gallbladder trouble; signs of low blood sugar; noticeably reduced urination; or any vision changes.
  • Call 911 for: swelling of the face, lips, tongue, or throat; difficulty breathing; severe stomach pain spreading to your back; or fainting.

This is not a complete list of side effects. Your pharmacy’s medication information sheet has the full details — read it before your first dose.

Interactions

Medications that interact

Tell your provider about every medication and supplement you take — prescription and over-the-counter. A few interactions matter in particular.

  • Insulin and sulfonylureas. Taking tirzepatide with these raises the risk of low blood sugar. Your provider may lower those doses when you start.
  • Oral birth control pills. Tirzepatide slows stomach emptying, which can make oral hormonal contraceptives less effective. Switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase.
  • Other oral medications. Slowed stomach emptying can change how some oral medications are absorbed — especially those needing precise timing or levels. Ask your provider whether any of yours are affected.
  • Alcohol. Can worsen nausea and, in people on blood-sugar medications, raise the risk of hypoglycemia. Use caution and discuss with your provider.
Pregnancy & Nursing

Not for use during pregnancy

Tirzepatide may cause harm to an unborn baby, and losing weight offers no benefit during pregnancy. If you become pregnant while using tirzepatide, stop taking it and contact your provider right away.

It is not known whether tirzepatide passes into breast milk — it is not recommended while breastfeeding. And if you use oral birth control pills, remember the interaction above: use a non-oral or added barrier method for 4 weeks after starting and after each dose increase.

Reporting & Support

If something doesn’t feel right

You are never on your own with this medication. For emergencies, call 911. For urgent but non-emergency concerns, contact the provider overseeing your care through the platform. And for anything else, we’re at [email protected].

  • Medical emergency — call 911 or go to the nearest emergency room.
  • Treatment questions or side effects — message the provider overseeing your care through the ILSA platform.
  • Report side effects to the FDA — you can report negative side effects of prescription drugs to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
  • Platform support — email [email protected] or call 754 227 9 227.

Compounded medication disclosure: if approved, prescriptions are dispensed by U.S.-based 503A compounding pharmacies that are registered with the FDA and operate in compliance with United States Pharmacopeia standards. Compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness, or manufacturing consistency. ILSA Health does not manufacture, compound, or directly dispense medications. ILSA is a telehealth platform that connects individuals with independent licensed providers and licensed U.S.-based pharmacies; it does not itself practice medicine or prescribe. Individual responses to treatment vary and no specific results are guaranteed. This page is educational only and is not medical advice.

Questions About Safety?

Talk It Through With a Provider

The best safety decision is an informed one. Start the online assessment and an independent licensed provider will review your health history, answer your questions, and determine whether tirzepatide is appropriate for you.

Provider-reviewed
Licensed U.S. pharmacies
No commitment until approved

Educational only — not medical advice. Tirzepatide is available only after review by an independent licensed provider, who determines whether it is appropriate based on your individual health history. Compounded medications are not FDA-approved. Individual responses vary and no specific results are guaranteed.

Licensed Medical Providers 100% Online Clear Pricing Shipped to Your Door HIPAA Compliant Shipped in 24–48 hrs Licensed Medical Providers 100% Online Clear Pricing Shipped to Your Door HIPAA Compliant Shipped in 24–48 hrs

Medical & Regulatory Notice

The health assessment offered through ILSA Health is designed for preliminary screening and educational purposes only. Completion of this questionnaire does not create a doctor–patient relationship.

All medical services, including clinical evaluations, treatment plans, and prescription decisions, are provided exclusively by independent U.S.-licensed healthcare providers. Providers exercise full medical judgment and determine eligibility based on individual clinical assessment and applicable state regulations.

If approved, prescriptions are dispensed by U.S.-based 503A compounding pharmacies that are registered with the FDA and operate in compliance with United States Pharmacopeia standards. Compounded medications are not FDA-approved and have not undergone FDA evaluation for safety, effectiveness, or manufacturing consistency.

Individual responses to treatment vary. No specific results are guaranteed.

ILSA Health does not manufacture, compound, or directly dispense medications. Product appearance, packaging, and labeling may vary from images shown on this website.

All trademarks and product names are the property of their respective owners.

© ILSA Health - 2026 All Rights Reserved

Clinic Designed By: Med Clinic Authority